(1.30%) 5 129.96 points
(1.27%) 38 712 points
(2.02%) 16 162 points
(-0.82%) $78.30
(5.31%) $2.14
(0.06%) $2 311.00
(-0.39%) $26.73
(0.39%) $966.40
(-0.35%) $0.929
(-1.23%) $10.86
(-0.10%) $0.797
(0.37%) $91.47
1.81% $ 77.14
@ $76.59
Emitido: 3 may 2024 @ 11:33
Retorno: 0.72%
Señal anterior: may 2 - 13:44
Señal anterior:
Retorno: 1.55 %
Live Chart Being Loaded With Signals
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders...
Stats | |
---|---|
Volumen de hoy | 2.53M |
Volumen promedio | 6.51M |
Capitalización de mercado | 8.51B |
EPS | $-0.250 ( 2024-04-24 ) |
Próxima fecha de ganancias | ( $-0.250 ) 2024-07-24 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -83.84 |
ATR14 | $4.80 (6.22%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Mancini Marianna | Buy | 51 000 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Sell | 23 746 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Sell | 26 142 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Buy | 35 426 | Common Stock, par value $0.00001 per share |
2024-05-01 | Mancini Marianna | Buy | 90 000 | Common Stock, par value $0.00001 per share |
INSIDER POWER |
---|
1.01 |
Last 100 transactions |
Buy: 2 844 296 | Sell: 2 903 733 |
Volumen Correlación
Viking Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
CFFE | 0.97 |
ARIZ | 0.966 |
EMLD | 0.96 |
ARTEU | 0.96 |
AIB | 0.958 |
GENQ | 0.956 |
FTII | 0.956 |
ABST | 0.955 |
GDST | 0.955 |
KIN | 0.954 |
10 Correlaciones Más Negativas | |
---|---|
SMFL | -0.968 |
CYAN | -0.963 |
MYSZ | -0.96 |
PIII | -0.958 |
CREG | -0.955 |
BCAB | -0.95 |
PYR | -0.95 |
SPCX | -0.949 |
KTTA | -0.948 |
VFF | -0.947 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Viking Therapeutics Inc Correlación - Moneda/Commodity
Viking Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-292 000 (0.00 %) |
EPS: | $-0.910 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-292 000 (0.00 %) |
EPS: | $-0.910 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-291 000 (0.00 %) |
EPS: | $-0.880 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-0.757 |
Financial Reports:
No articles found.
Viking Therapeutics Inc
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico